- Why Invest
- Business Operations
- Key Industries
- How We Help
- Contact Us
The Dutch Life Sciences & Health sector is dynamic, innovative and collaborative. It is characterized by outstanding hubs and clusters linked by first-class physical and digital infrastructure. Home to 3000+ innovative life sciences businesses, including 400+ biopharmaceutical companies, the European Medicines Agency, and thousands of MedTech companies, the Netherlands is one of the most concentrated Life Science & Health clusters in the world, all situated within a 2.5-hour drive radius!
This webinar for entrepreneurs and professionals in Biotech, MedTech and Cell & Gene therapy addresses everything you always wanted to know about the connected life sciences community and the regulatory environment in the Netherlands. Learn practical strategies to harness the Dutch advantage and accelerate your company’s growth.
17.00-17.20 CET: Deep-dive on Biotech and Cell & Gene therapy opportunities in the Netherlands – Invest in Holland Team
17.20-17.30 CET: The roadmap to setting up your life sciences company in the Netherlands – Gunar Gijsbrechts, Scribes Tax Lawyers
17.30-17.45 CET: Regulations in the EU – Opportunities, challenges & how to approach these by Hanneke Later-Nijland, Genome Lawyers
17.45-17.55 CET: Inspirational success story from a company’s journey in this vibrant landscape – NanoCell Therapeutics
17.55-18.15 CET: Q&A – The Invest in Holland team, together with Scribes Tax Lawyers will answer all your questions.
This webinar will provide you with in-depth knowledge about the advantages of selecting the Netherlands as the ideal location to start or grow your life sciences business. After, you’ll have a comprehensive grasp of the vast opportunities and resources at your disposal in this dynamic region.
We’re looking forward to connecting with you on November 30th at 17:00 CET / 9:00 am PDT. For any queries or additional information, please feel free to reach out.
The Netherlands ranks top 5 in the world in the field of regenerative medicine and the Netherlands is now one of the few places in Europe where (stem) cell therapy is also applied and developed clinically. In the last two years, several foreign companies have established European cell therapy manufacturing and R&D facilities in the Netherlands, including Kite, Fujifilm Irvine Scientific and Bristol Myers Squibb (BMS). The Netherlands’ high concentration of world-leading research talent, its business-oriented R&D facilities, startups and multinationals, and a supportive government, all make the Netherlands an attractive country for cell and gene therapy companies.
Learn more about the Dutch Biotech Ecosystem or how the Netherlands is advancing digital health care and the many international life sciences companies that found fertile ground in the Netherlands to accelerate their business and benefit people and the planet.
Interested in opportunities for your company in the Netherlands? Read our new Dutch Life Sciences & Health Magazine.